Logo image of TGEN

TECOGEN INC/WALTHAM MA (TGEN) Stock Fundamental Analysis

NYSEARCA:TGEN - NYSE Arca - US87876P2011 - Common Stock - Currency: USD

9.18  -0.5 (-5.17%)

After market: 9.17 -0.01 (-0.11%)

Fundamental Rating

3

Taking everything into account, TGEN scores 3 out of 10 in our fundamental rating. TGEN was compared to 41 industry peers in the Building Products industry. While TGEN seems to be doing ok healthwise, there are quite some concerns on its profitability. TGEN is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

TGEN had negative earnings in the past year.
In the past year TGEN had a positive cash flow from operations.
TGEN had negative earnings in 4 of the past 5 years.
In multiple years TGEN reported negative operating cash flow during the last 5 years.
TGEN Yearly Net Income VS EBIT VS OCF VS FCFTGEN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M -4M -6M

1.2 Ratios

With a Return On Assets value of -15.31%, TGEN is not doing good in the industry: 87.80% of the companies in the same industry are doing better.
Looking at the Return On Equity, with a value of -46.53%, TGEN is doing worse than 87.80% of the companies in the same industry.
Industry RankSector Rank
ROA -15.31%
ROE -46.53%
ROIC N/A
ROA(3y)-13.51%
ROA(5y)-9.91%
ROE(3y)-30.18%
ROE(5y)-21.73%
ROIC(3y)N/A
ROIC(5y)N/A
TGEN Yearly ROA, ROE, ROICTGEN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40

1.3 Margins

The Gross Margin of TGEN (43.64%) is better than 82.93% of its industry peers.
TGEN's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for TGEN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 43.64%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.79%
GM growth 5Y3.17%
TGEN Yearly Profit, Operating, Gross MarginsTGEN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

More info and screens

5

2. Health

2.1 Basic Checks

TGEN does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, TGEN has more shares outstanding
The number of shares outstanding for TGEN has been increased compared to 5 years ago.
Compared to 1 year ago, TGEN has a worse debt to assets ratio.
TGEN Yearly Shares OutstandingTGEN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
TGEN Yearly Total Debt VS Total AssetsTGEN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

2.2 Solvency

An Altman-Z score of 6.13 indicates that TGEN is not in any danger for bankruptcy at the moment.
With a decent Altman-Z score value of 6.13, TGEN is doing good in the industry, outperforming 73.17% of the companies in the same industry.
The Debt to FCF ratio of TGEN is 0.63, which is an excellent value as it means it would take TGEN, only 0.63 years of fcf income to pay off all of its debts.
TGEN's Debt to FCF ratio of 0.63 is amongst the best of the industry. TGEN outperforms 90.24% of its industry peers.
TGEN has a Debt/Equity ratio of 0.18. This is a healthy value indicating a solid balance between debt and equity.
TGEN has a better Debt to Equity ratio (0.18) than 70.73% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF 0.63
Altman-Z 6.13
ROIC/WACCN/A
WACC8.83%
TGEN Yearly LT Debt VS Equity VS FCFTGEN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M

2.3 Liquidity

TGEN has a Current Ratio of 1.32. This is a normal value and indicates that TGEN is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of TGEN (1.32) is worse than 82.93% of its industry peers.
A Quick Ratio of 0.74 indicates that TGEN may have some problems paying its short term obligations.
TGEN has a Quick ratio of 0.74. This is amonst the worse of the industry: TGEN underperforms 82.93% of its industry peers.
Industry RankSector Rank
Current Ratio 1.32
Quick Ratio 0.74
TGEN Yearly Current Assets VS Current LiabilitesTGEN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

More info and screens

4

3. Growth

3.1 Past

TGEN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -220.48%.
TGEN shows a small growth in Revenue. In the last year, the Revenue has grown by 2.46%.
Measured over the past years, TGEN shows a decrease in Revenue. The Revenue has been decreasing by -5.52% on average per year.
EPS 1Y (TTM)-220.48%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)2.46%
Revenue growth 3Y-9.23%
Revenue growth 5Y-5.52%
Sales Q2Q%17.68%

3.2 Future

TGEN is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 42.99% yearly.
The Revenue is expected to grow by 23.49% on average over the next years. This is a very strong growth
EPS Next Y-53%
EPS Next 2Y-23.69%
EPS Next 3Y57.92%
EPS Next 5Y42.99%
Revenue Next Year-2.95%
Revenue Next 2Y8.41%
Revenue Next 3Y27.53%
Revenue Next 5Y23.49%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
TGEN Yearly Revenue VS EstimatesTGEN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 20M 40M 60M 80M 100M
TGEN Yearly EPS VS EstimatesTGEN Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.2 -0.2 0.4 0.6

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for TGEN. In the last year negative earnings were reported.
Also next year TGEN is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
TGEN Price Earnings VS Forward Price EarningsTGEN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40 -60 -80

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, TGEN is valued a bit more expensive than 73.17% of the companies in the same industry.
Industry RankSector Rank
P/FCF 87.78
EV/EBITDA N/A
TGEN Per share dataTGEN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6

4.3 Compensation for Growth

TGEN's earnings are expected to grow with 57.92% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-23.69%
EPS Next 3Y57.92%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for TGEN!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

TECOGEN INC/WALTHAM MA

NYSEARCA:TGEN (8/1/2025, 8:06:00 PM)

After market: 9.17 -0.01 (-0.11%)

9.18

-0.5 (-5.17%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryBuilding Products
Earnings (Last)05-12 2025-05-12/amc
Earnings (Next)08-12 2025-08-12
Inst Owners0.05%
Inst Owner Change8024.81%
Ins Owners31.76%
Ins Owner Change5.96%
Market Cap271.36M
Analysts82.86
Price TargetN/A
Short Float %6.18%
Short Ratio1.08
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-31.96%
Min Revenue beat(2)-33.4%
Max Revenue beat(2)-30.52%
Revenue beat(4)0
Avg Revenue beat(4)-30.88%
Min Revenue beat(4)-39.65%
Max Revenue beat(4)-19.94%
Revenue beat(8)2
Avg Revenue beat(8)-17.83%
Revenue beat(12)3
Avg Revenue beat(12)-15.77%
Revenue beat(16)4
Avg Revenue beat(16)-15.85%
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 12
P/FCF 87.78
P/OCF 66.83
P/B 26.52
P/tB 50.53
EV/EBITDA N/A
EPS(TTM)-0.1
EYN/A
EPS(NY)-0.15
Fwd EYN/A
FCF(TTM)0.1
FCFY1.14%
OCF(TTM)0.14
OCFY1.5%
SpS0.77
BVpS0.35
TBVpS0.18
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -15.31%
ROE -46.53%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 43.64%
FCFM 13.67%
ROA(3y)-13.51%
ROA(5y)-9.91%
ROE(3y)-30.18%
ROE(5y)-21.73%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.79%
GM growth 5Y3.17%
F-Score4
Asset Turnover0.73
Health
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF 0.63
Debt/EBITDA N/A
Cap/Depr 175.01%
Cap/Sales 4.28%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.32
Quick Ratio 0.74
Altman-Z 6.13
F-Score4
WACC8.83%
ROIC/WACCN/A
Cap/Depr(3y)87.45%
Cap/Depr(5y)67.63%
Cap/Sales(3y)1.94%
Cap/Sales(5y)1.42%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-220.48%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y-53%
EPS Next 2Y-23.69%
EPS Next 3Y57.92%
EPS Next 5Y42.99%
Revenue 1Y (TTM)2.46%
Revenue growth 3Y-9.23%
Revenue growth 5Y-5.52%
Sales Q2Q%17.68%
Revenue Next Year-2.95%
Revenue Next 2Y8.41%
Revenue Next 3Y27.53%
Revenue Next 5Y23.49%
EBIT growth 1Y2.75%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y457.51%
FCF growth 3Y112.98%
FCF growth 5YN/A
OCF growth 1Y596.53%
OCF growth 3Y105.19%
OCF growth 5YN/A